Moreover, the level of ExoPD-L1 in gastric cancer patients has also been found to be negatively associated with the number of CD8+ T and CD4+ T cells, as well as with CD69 (a T-cell activation marker) and PD-1 of CD8+ effector T cells. The gene discussed is CD8A; the disease is gastric cancer.